BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30156265)

  • 1. A novel approach to the classification of epidermodysplasia verruciformis.
    Huang S; Wu JH; Lewis DJ; Rady PL; Tyring SK
    Int J Dermatol; 2018 Nov; 57(11):1344-1350. PubMed ID: 30156265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
    Przybyszewska J; Zlotogorski A; Ramot Y
    J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
    Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
    Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
    Imahorn E; Yüksel Z; Spoerri I; Gürel G; Imhof C; Saraçoğlu ZN; Koku Aksu AE; Rady PL; Tyring SK; Kempf W; Itin PH; Burger B
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1722-1726. PubMed ID: 28646613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
    Orth G
    Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
    O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
    Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple flat-topped scaly violaceous papules.
    Girijala RL; Nyinawinyange D; Parekh PK; Grimwood RE
    Dermatol Online J; 2019 Mar; 25(3):. PubMed ID: 30982308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
    McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
    Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciformis associated with HPV 10.
    Zahir A; Craig L; Rady P; Tyring S; Ehrlich A
    Dermatol Online J; 2013 Apr; 19(4):2. PubMed ID: 24021362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
    Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
    J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
    Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
    J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermodysplasia verruciformis.
    Burger B; Itin PH
    Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
    Orth G
    Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired epidermodysplasia verruciformis.
    Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
    J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermodysplasia verruciform-like Lesions in an HIV patient.
    Berk DR; Bruckner AL; Lu D
    Dermatol Online J; 2009 Jan; 15(1):1. PubMed ID: 19281706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
    Sun XK; Chen JF; Xu AE
    Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
    Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
    J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
    Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
    BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
    Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
    PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
    Orth G
    Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.